Table 2.
Analysis Performed | ANOVA Results | p Values |
---|---|---|
PCC GFAP–CD73 | F(2, 28) = 0.7792 | p = 0.4736 |
PCC IBA1–CD73 | F(2, 31) = 33.48 | p < 0.0001 |
MCC1 GFAP–CD73 | F(2, 28) = 3.228 | p = 0.0648 |
MCC2 CD73-GFAP | F(2, 28) = 4.975 | p < 0.05 |
MCC1 IBA1–CD73 | F(2, 27) = 5.482 | p < 0.05 |
MCC2 CD73–IBA1 | F(2, 27) = 17.05 | p < 0.0001 |
PCC A1R–CD73 | F(2, 30) = 22.19 | p < 0.0001 |
PCC IBA1–A1R | F(2, 28) = 9.155 | p < 0.01 |
MCC1 GFAP–A1R | F(2, 27) = 24.45 | p < 0.0001 |
MCC2 A1R-GFAP | F(2, 27) = 9.217 | p < 0.01 |
MCC1 IBA1–A1R | F(2, 28) = 9.502 | p < 0.01 |
MCC2 A1R–IBA1 | F(2, 28) = 5.458 | p < 0.05 |
PCC GFAP–A2AR | F(2, 33) = 12.74 | p < 0.001 |
PCC IBA1–A2AR | F(2, 32) = 25.23 | p < 0.0001 |
MCC1 GFAP–A2AR | F(2, 26) = 20.86 | p < 0.0001 |
MCC2 A2AR-GFAP | F(2, 27) = 8.629 | p < 0.01 |
MCC1 IBA1–A2AR | F(2, 29) = 10.93 | p < 0.001 |
MCC2 A2AR–IBA1 | F(2, 29) = 31.472 | p < 0.0001 |